Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 685,182 | 685,192 | +10 | $38.75M | $41.79M | 36.29% | +$3.04M |
| Corcept Therapeutics Incorporated(CORT) | 74,000 | 66,000 | -8,000 | $3.73M | $7.54M | 6.55% | +$3.81M |
| Acadia Pharmaceuticals Inc | 338,400 | 263,400 | -75,000 | $6.21M | $4.38M | 3.80% | -$1.83M |
| Prothena Corp PlcSHS SHS | 304,574 | 332,974 | +28,400 | $4.22M | $4.12M | 3.58% | -$97.8K |
| Biodesix, Inc.(BDSX) | 5,736,113 | 5,736,113 | 0 | $8.78M | $3.59M | 3.11% | -$5.19M |
| Neurocrine Biosciences, Inc.(NBIX) | 30,240 | 30,240 | 0 | $4.13M | $3.34M | 2.90% | -$783.2K |
| Elutia Inc.(ELUT) | 1,225,489 | 1,187,735 | -37,754 | $4.58M | $3.00M | 2.61% | -$1.58M |
| Axogen, Inc.(AXGN) | 197,000 | 161,000 | -36,000 | $3.25M | $2.98M | 2.59% | -$268.1K |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $2.89M | $2.93M | 2.55% | +$45.9K |
| Travere Therapeutics, Inc.(TVTX) | 148,000 | 138,000 | -10,000 | $2.58M | $2.47M | 2.15% | -$105.2K |
| Quidelortho Corp | 67,619 | 67,619 | 0 | $3.01M | $2.36M | 2.05% | -$647.8K |
| Protagonist Therapeutics Inc | 48,000 | 48,002 | +2 | $1.85M | $2.32M | 2.02% | +$468.6K |
| United Therapeutics Corporation(UTHR) | 10,000 | 7,500 | -2,500 | $3.53M | $2.31M | 2.01% | -$1.22M |
| DocGo Inc.(DCGO) | 764,062 | 864,062 | +100,000 | $3.24M | $2.28M | 1.98% | -$958.5K |
| Ovintiv Inc.(OVV) | 52,200 | 52,200 | 0 | $2.11M | $2.23M | 1.94% | +$120.1K |
| Harrow, Inc.(HROW) | 72,910 | 72,910 | 0 | $2.45M | $1.94M | 1.68% | -$506.7K |
| Masimo Corp | 15,280 | 11,280 | -4,000 | $2.53M | $1.88M | 1.63% | -$646.5K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.60M | $1.85M | 1.61% | +$253.4K |
| Castle Biosciences, Inc.(CSTL) | 78,000 | 88,404 | +10,404 | $2.08M | $1.77M | 1.54% | -$308.9K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.44M | $1.65M | 1.43% | +$213.0K |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 210,005 | +5 | $2.32M | $1.40M | 1.21% | -$919.8K |
| Treace Medical Concepts, Inc.(TMCI) | 161,350 | 164,947 | +3,597 | $1.20M | $1.38M | 1.20% | +$183.5K |
| Foghorn Therapeutics Inc.(FHTX) | 310,930 | 310,930 | 0 | $1.47M | $1.13M | 0.99% | -$332.7K |
| uniQure N.V.SHS(QURE) | 20,000 | 88,697 | +68,697 | $353.2K | $940.2K | 0.82% | +$587.0K |
| Kalvista Pharmaceuticals Inc | 67,000 | 67,002 | +2 | $567.5K | $773.2K | 0.67% | +$205.7K |
| Xenon Pharmaceuticals Inc.(XENE) | 10,000 | 21,000 | +11,000 | $392.0K | $704.5K | 0.61% | +$312.6K |
| Axsome Therapeutics, Inc.(AXSM) | 4,000 | 6,000 | +2,000 | $338.4K | $699.8K | 0.61% | +$361.3K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,006 | +6 | $593.4K | $666.4K | 0.58% | +$73.0K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $478.1K | $638.1K | 0.55% | +$160.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 16,000 | 16,000 | 0 | $673.1K | $579.4K | 0.50% | -$93.8K |
| NovoCure Limited(NVCR) | 31,000 | 31,000 | 0 | $923.8K | $552.4K | 0.48% | -$371.4K |
| Scholar Rock Holding Corporation(SRRK) | 8,000 | 16,000 | +8,000 | $345.8K | $514.4K | 0.45% | +$168.6K |
| OrthoPediatrics Corp.(KIDS) | 0 | 20,000 | +20,000 | $0 | $492.6K | 0.43% | +$492.6K |
| Solid Biosciences Inc | 0 | 128,768 | +128,768 | $0 | $476.4K | 0.41% | +$476.4K |
| Inhibrx Biosciences, Inc.(INBX) | 32,110 | 32,110 | 0 | $494.5K | $449.2K | 0.39% | -$45.3K |
| 10x Genomics, Inc.CL A(TXG) | 50,000 | 50,000 | 0 | $718.0K | $436.5K | 0.38% | -$281.5K |
| Cytokinetics, Incorporated(CYTK) | 10,000 | 10,000 | 0 | $470.4K | $401.9K | 0.35% | -$68.5K |
| Springworks Therapeutics Inc | 10,000 | 8,280 | -1,720 | $361.3K | $365.4K | 0.32% | +$4.1K |
| Pulmonx Corporation(LUNG) | 51,000 | 51,000 | 0 | $346.3K | $343.2K | 0.30% | -$3.1K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 60,000 | 0 | $520.8K | $339.0K | 0.29% | -$181.8K |
| Alphatec Holdings, Inc.(ATEC) | 58,000 | 33,000 | -25,000 | $532.4K | $334.6K | 0.29% | -$197.8K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,000 | 40,300 | +300 | $494.8K | $325.6K | 0.28% | -$169.2K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 4,000 | 8,000 | +4,000 | $216.6K | $312.6K | 0.27% | +$96.0K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $446.7K | $306.2K | 0.27% | -$140.6K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 40,000 | 40,000 | 0 | $300.8K | $300.0K | 0.26% | -$800 |
| Apogee Therapeutics Inc | 0 | 8,000 | +8,000 | $0 | $298.9K | 0.26% | +$298.9K |
| Xencor, Inc.(XNCR) | 26,000 | 26,000 | 0 | $597.5K | $276.6K | 0.24% | -$320.8K |
| Outset Medical, Inc.(OM) | 368,766 | 24,584 | -344,182 | $409.3K | $271.9K | 0.24% | -$137.4K |
| Blueprint Medicines Corp | 2,700 | 2,700 | 0 | $235.5K | $239.0K | 0.21% | +$3.5K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $263.8K | $228.5K | 0.20% | -$35.3K |
| Accelerate Diagnostics Inc | 325,239 | 325,239 | 0 | $390.3K | $228.0K | 0.20% | -$162.3K |
| Arvinas, Inc.(ARVN) | 15,000 | 30,000 | +15,000 | $287.6K | $210.6K | 0.18% | -$77.0K |
| NeuroPace, Inc.(NPCE) | 10,000 | 16,442 | +6,442 | $111.9K | $202.1K | 0.18% | +$90.2K |
| TELA Bio, Inc.(TELA) | 125,000 | 155,000 | +30,000 | $377.5K | $189.1K | 0.16% | -$188.4K |
| Keros Therapeutics, Inc.(KROS) | 15,000 | 15,000 | 0 | $237.4K | $152.8K | 0.13% | -$84.6K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $125.0K | $152.0K | 0.13% | +$27.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $243.6K | $151.4K | 0.13% | -$92.2K |
| Liquidia Corporation(LQDA) | 10,000 | 10,013 | +13 | $117.6K | $147.7K | 0.13% | +$30.1K |
| Direxion Daily Pharmaceutical & Medical Bull 3x ShDLY TECH BULL 3X DA TE BU 3X ETF | 18,000 | 20,000 | +2,000 | $127.8K | $144.4K | 0.13% | +$16.6K |
| Atara Biotherapeutics Inc | 22,000 | 22,000 | 0 | $292.8K | $130.7K | 0.11% | -$162.1K |
| Zenas BioPharma, Inc.(ZBIO) | 16,500 | 16,500 | 0 | $135.1K | $130.3K | 0.11% | -$4.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 419,832 | 27,985 | -391,847 | $283.9K | $104.7K | 0.09% | -$179.3K |
| 2seventy Bio Inc | 15,833 | 15,500 | -333 | $46.5K | $76.6K | 0.07% | +$30.0K |
| Alumis Inc | 10,000 | 10,000 | 0 | $78.6K | $61.4K | 0.05% | -$17.2K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $123.5K | $51.0K | 0.04% | -$72.5K |
| Compass Therapeutics, Inc.(CMPX) | 0 | 24,000 | +24,000 | $0 | $45.6K | 0.04% | +$45.6K |
| Ventyx Biosciences Inc | 28,800 | 28,800 | 0 | $63.1K | $33.1K | 0.03% | -$30.0K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,000 | 17,000 | 0 | $51.5K | $27.0K | 0.02% | -$24.5K |
| Biohaven Pharmaceutical Holding Co Ltd | 7,365 | 0 | -7,365 | $275.1K | $0 | — | -$275.1K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 12,972 | 0 | -12,972 | $778 | $0 | — | -$778 |
| Coherus Oncology, Inc.(CHRS) | 82,000 | 0 | -82,000 | $113.2K | $0 | — | -$113.2K |
| Sarepta Therapeutics, Inc.(SRPT) | 3,500 | 0 | -3,500 | $425.6K | $0 | — | -$425.6K |